Filing Details
- Accession Number:
- 0001209191-21-051321
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-13 10:13:08
- Reporting Period:
- 2021-08-11
- Accepted Time:
- 2021-08-13 10:13:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1742194 | D. John Manders | 9924 West 74Th Street Eden Prairie MN 55344 | Corporate Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-11 | 2,608 | $22.95 | 5,716 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-11 | 2,555 | $53.33 | 3,161 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-11 | 53 | $54.24 | 3,108 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-08-11 | 2,608 | $0.00 | 2,608 | $22.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-05-03 | No | 4 | M | Direct |
Footnotes
- Reflects the weighted average price of 2,555 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 11, 2021 with sale prices ranging from $53.1458 to $53.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
